| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 01/31/2001 | EP1071752A1 CD19xCD3 SPECIFIC POLYPEPTIDES AND USES THEREOF |
| 01/31/2001 | EP1071718A1 Matrix binding factor |
| 01/31/2001 | EP1071717A1 Mutagenized il13-based chimeric molecules |
| 01/31/2001 | EP1071706A1 Rapidly degrading gfp-fusion proteins and methods of use |
| 01/31/2001 | EP1071469A2 Enhancement of antibody-cytokine fusion protein mediated immune responses by co-administration with prostaglandin inhibitor |
| 01/31/2001 | EP1071468A2 Enhancement of antibody-cytokine fusion protein mediated immune responses by co-administration with angiogenesis inhibitor |
| 01/31/2001 | EP1071460A1 INTERNALIZING ErbB2 ANTIBODIES |
| 01/31/2001 | CN1282255A IFNAR2/I FN complex |
| 01/30/2001 | US6180371 Modified factor VIII |
| 01/30/2001 | US6180370 Preparing preferential antibodies; generating nucleotide sequences coding preferential antibodies, expressing nucleotide sequences in transformed cell and recovering preferential antibodies |
| 01/30/2001 | US6180343 Green fluorescent protein fusions with random peptides |
| 01/25/2001 | WO2001005990A1 Structural protein of adeno-associated virus with modified antigenicity, its production and its use |
| 01/25/2001 | WO2001005972A1 Compositions and methods for the treatment of immune related diseases |
| 01/25/2001 | WO2001005831A1 Modulation of human sodium channels in dorsal root ganglia |
| 01/25/2001 | WO2001005826A2 Chimeric polypeptides of serum albumin and uses related thereto |
| 01/25/2001 | WO2001005808A2 In vitro selection and optional identification of polypeptides using solid support carriers |
| 01/25/2001 | WO2001005418A2 Tissue regenerating agent |
| 01/25/2001 | WO2000058465A3 Flint polypeptide analogs |
| 01/25/2001 | CA2379391A1 Modulation of human sodium channels in dorsal root ganglia |
| 01/25/2001 | CA2379143A1 In vitro selection and optional identification of polypeptides using solid support carriers |
| 01/25/2001 | CA2376641A1 Chimeric polypeptides of serum albumin and uses related thereto |
| 01/25/2001 | CA2375458A1 Compositions and methods for the treatment of immune related diseases |
| 01/24/2001 | EP1070085A1 DUAL A v?b 3? AND METASTASIS-ASSOCIATED RECEPTOR LIGANDS |
| 01/23/2001 | US6177272 Method for treating vascular proliferative diseases with p27 and fusions thereof |
| 01/23/2001 | US6177079 Monoclonal antibodies against interleukins |
| 01/18/2001 | WO2001004344A2 Induction of a th1-like response in vitro |
| 01/18/2001 | WO2001004304A1 Human cytokine receptor |
| 01/18/2001 | WO2001004292A1 G-protein coupled receptor and dna sequences thereof |
| 01/18/2001 | WO2001004287A1 A method for preparing modified polypeptides |
| 01/18/2001 | WO2001004269A1 Ligands for use in therapeutic compositions for the treatment of hemostasis disorders |
| 01/18/2001 | WO2001004151A2 TUBERCULOSIS VACCINE AND DIAGNOSTICS BASED ON THE MYCOBACTERIUM TUBERCULOSIS esat-6 GENE FAMILY |
| 01/18/2001 | WO2001004148A2 Donor strand complemented pilin and adhesin broad-based vaccines |
| 01/18/2001 | WO2001004141A2 Seripancrin |
| 01/18/2001 | WO2001004140A1 Compounds for treatment of infectious and immune system disorders and methods for their use |
| 01/18/2001 | WO2001003737A1 Immunoglobulin fusion proteins |
| 01/18/2001 | WO2001003723A1 Hybrid polypeptides with enhanced pharmacokinetic properties |
| 01/18/2001 | WO2000066755A3 Pesticidal fusions |
| 01/18/2001 | WO2000063378A3 Zalpha13: a human secreted protein |
| 01/18/2001 | WO2000023565B1 Novel neuropilin/growth factor binding and uses thereof |
| 01/18/2001 | WO2000002911A3 INTERACTION OF HUMAN BETA AMYLOID PRECURSOR PROTEIN (β-APP) WITH HUMAN LON-PROTEASE LIKE PROTEIN (HSLON) |
| 01/18/2001 | DE19933288A1 Strukturprotein von Adeno-assoziiertem Virus mit veränderter Antigenität, seine Herstellung und Verwendung Structural protein of adeno-associated virus with altered antigenicity, its preparation and use |
| 01/18/2001 | DE19933089A1 Mittel zur Gewerbsregeneration Means for commercial regeneration |
| 01/18/2001 | CA2383496A1 Compounds for treatment of infectious and immune system disorders and methods for their use |
| 01/18/2001 | CA2381125A1 Ligands for use in therapeutic compositions for the treatment of hemostasis disorders |
| 01/18/2001 | CA2378796A1 Seripancrin |
| 01/18/2001 | CA2378786A1 G-protein coupled receptor and dna sequences thereof |
| 01/18/2001 | CA2378763A1 Tuberculosis vaccine and diagnostics based on the mycobacterium tuberculosis esat-6 gene family |
| 01/18/2001 | CA2378097A1 Induction of a th1-like response in vitro |
| 01/18/2001 | CA2377677A1 Hybrid polypeptides with enhanced pharmacokinetic properties |
| 01/18/2001 | CA2373534A1 Donor strand complemented pilin and adhesin broad-based vaccines |
| 01/17/2001 | EP1068329A2 FUSION PROTEINS OF $i(MYCOBACTERIUM TUBERCULOSIS) ANTIGENS AND THEIR USES |
| 01/17/2001 | EP1068314A1 Highly active forms of interferon regulatory factor proteins |
| 01/17/2001 | EP1068241A1 Antibody variants and fragments thereof |
| 01/17/2001 | EP1068228A1 Protease conjugates |
| 01/17/2001 | EP1067954A1 USE OF ANTI-gp39 ANTIBODIES FOR TREATMENT AND/OR REVERSAL OF LUPUS AND ASSOCIATED KIDNEY DISEASE |
| 01/17/2001 | EP0771216B1 Methods and compositions for the specific coagulation of tumoral vasculature |
| 01/17/2001 | CN1280627A Proteinase inhibitor fusion proteins |
| 01/17/2001 | CN1280619A (Chlamydia trachomatic) genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
| 01/17/2001 | CN1280137A Erythrocyte-stimulating factor coupling |
| 01/16/2001 | US6174721 Protein having kunitz-type domains of tissue factor pathway inhibitors and lacking glycosylation sites; for prevention and treatment of septic shock |
| 01/16/2001 | US6174674 Detecting nucleotide sequence adjustment; hybridizing centromeric probe to human sample, hybridizing second teleomeric probe to human sample, detecting centromeric and telomeric hybridization positioning |
| 01/16/2001 | US6174528 Inducing protective antibodies against group a streptococci |
| 01/16/2001 | CA2029861C Diagnosis and treatment of insulin dependent diabetes mellitus |
| 01/16/2001 | CA1341166C Antigenic proteins and vaccines containing them for prevention of coccidiosis |
| 01/11/2001 | WO2001002565A2 Secreted protein zacrp4 |
| 01/11/2001 | WO2001002440A1 Fusion peptides comprising a peptide ligand domain and a multimerization domain |
| 01/11/2001 | WO2001002019A2 Control of gene expression |
| 01/11/2001 | WO2001001748A2 Peptide compounds that bind her2 |
| 01/11/2001 | WO2000066739A3 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 01/11/2001 | WO2000058466A3 Protease resistant flint analogs |
| 01/11/2001 | WO2000047622A3 Peptides with anti-angiogenic activity |
| 01/11/2001 | WO2000039278A8 Pth functional domain conjugate peptides, derivatives thereof and novel tethered ligand-receptor molecules |
| 01/11/2001 | CA2378951A1 Secreted protein zacrp4 |
| 01/11/2001 | CA2377731A1 Fusion peptides comprising a peptide ligand domain and a multimerization domain |
| 01/11/2001 | CA2376166A1 Control of gene expression |
| 01/10/2001 | EP1067142A1 Antibody against cleavage product of vimentin |
| 01/10/2001 | EP1066380A2 Soluble t cell receptor |
| 01/10/2001 | EP1066378A2 Lyst protein complexes and lyst interacting proteins |
| 01/10/2001 | EP1066328A1 Chimeric protein containing an intramolecular chaperone-like sequence and its application to insulin production |
| 01/10/2001 | EP1066322A1 Circularly permuted biotin binding proteins |
| 01/10/2001 | EP1066320A1 Orphan nuclear receptor |
| 01/10/2001 | EP1066054A2 Use of active p40 conjugates for nasal delivery |
| 01/09/2001 | US6172194 ARF-p19, a novel regulator of the mammalian cell cycle |
| 01/09/2001 | US6172192 Polypeptide or peptide associated microorganism infection; for diagnosis and prevention protozoan infection of mammals |
| 01/09/2001 | US6172188 Fluorescent proteins |
| 01/09/2001 | US6172041 Nervous system disorders |
| 01/09/2001 | US6171861 Recombinational cloning using engineered recombination sites |
| 01/09/2001 | US6171827 Procollagens |
| 01/09/2001 | US6171783 Detecting parainfluenza virus-3 and respiratory syncytial virus infection by using fusion protein of antigenic proteins from both viruses |
| 01/08/2001 | CA2274880A1 Icam-6 materials and methods |
| 01/04/2001 | WO2001001150A2 Diagnostic test for thrombotic or thromboembolic disease |
| 01/04/2001 | WO2001000841A1 Insecticidal proteins from paecilomyces and synergistic combinations thereof |
| 01/04/2001 | WO2001000828A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 01/04/2001 | WO2001000648A1 Stabilized viral envelope proteins and uses thereof |
| 01/04/2001 | WO2001000237A1 Synthetic peptide immunogens and antibodies thereto |
| 01/04/2001 | WO2001000235A1 Prion protein binding proteins and uses thereof |
| 01/04/2001 | WO2000029438A9 Egf-like nucleic acids and polypeptides and uses thereof |
| 01/04/2001 | WO2000026251A9 A COMPLEX OF A CHAPERONE WITH ss-AMYLOID AND METHODS EMPLOYING THIS COMPLEX |
| 01/04/2001 | CA2594262A1 Corynebacterium glutamicum genes encoding proteins involved in carbon metabolism and energy production |
| 01/04/2001 | CA2594201A1 Corynebacterium glutamicum genes encoding proteins involved in carbon metabolism and energy production |